STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)						3 Months Ended
	Feb. 21, 2024	Feb. 10, 2024	Nov. 22, 2023	Sep. 22, 2023	Apr. 17, 2023	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023	Oct. 11, 2023	Aug. 10, 2022
Subsidiary, Sale of Stock [Line Items]
Common stock, shares issued						5,766,704		3,914,338
Value per common share						$ 0.0001		$ 0.0001		$ 37.71
Stock Issued During Period, Shares, Restricted Stock Award, Forfeited					1,203,704
Sale of stock, description of transaction						(ii) in consideration therefor, the Company would issue upon close of the IPO, and regardless of whether the Company would have issued any shares of Series B Preferred Stock, an aggregate of 4,167 shares (such shares, the “Standby Shares”) of Common Stock to the Standby Investor (such agreement, the “Series B Securities Purchase Agreement”). In addition, pursuant to the Series B Securities Purchase Agreement, the Company was required to file a registration statement within 180 calendar days after consummation of the IPO, providing for the resale of the Standby Shares and shares of Common Stock issuable upon conversion of the Series B Preferred Stock, if issued.
Common stock, shares issued						$ (214,757)
Company's intellectual property										$ 44,800,000
Common shares outstanding (as converted)						5,766,704		3,914,338		1,187,302
Total number of options granted						0	106,669
Exercise price for options						$ 22.68
Intrinsic value						$ 0
Amortization						292,552	$ 272,221
Unamortized stock option expense						$ 1,561,727
Period for the unamortized stock compensation						2 years 1 month 9 days
Total number of options granted						55,000	0
Exercise price for options						$ 7.50
Intrinsic value						$ 0
Description of warrants issued	the Company issued warrants to purchase up to 55,000 shares of Common Stock to the representative of the underwriters of the IPO (the “Representative”). These warrants have an exercise price of $7.50, have a cashless exercise provision, are exercisable 180 days following the commencement of sales of the shares of Common Stock of the IPO and have an expiration date of February 21, 2029.
Recission Agreement [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock, shares issued		111,129
Common stock, shares issued		$ 91,513
Right Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock, shares issued				2,533,853
Common stock, shares issued				$ 255,412
Series B Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Shaes issue to investor									750
Shaes par value									$ 0.0001
Purchase price of shares									$ 1,000
Series A Preferred Stock [Member]
Subsidiary, Sale of Stock [Line Items]
Shaes issue to investor						0		600,000
Shaes par value						$ 0.0001		$ 0.0001
Conversion of the series A convertible preferred stock										600,000
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Common stock, shares issued	1,100,000
Value per common share	$ 6.00
Aggregate net proceeds	$ 5,700,000
IPO [Member] | Right Offering [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of stock, description of transaction			the Company commenced a rights offering (the “Rights Offering”) pursuant to which the Company distributed non-transferable subscription rights (“Subscription Rights”) to each holder of its Common Stock held as of 5:00 p.m. Eastern Standard Time on November 22, 2023, the record date for the Rights Offering (the “Rights Offering Record Date”). The Subscription Rights could be exercised at any time during the subscription period, which commenced on November 22, 2023 and expired at 5:00 p.m., Eastern Standard Time, on December 1, 2023. Each Subscription Right entitled the eligible holder to purchase up to three shares of the Company’s Common Stock at a price per whole share of Common Stock of $0.1008 (the “Subscription Price”). Holders who fully exercised their rights could also subscribe for additional shares of Common Stock not subscribed for by other holders on a pro rata basis. In addition, the Company could distribute to one or more additional persons, at no charge to such person, additional non-transferable subscription rights to purchase shares of its Common Stock in the Rights Offering at the same Subscription Price, without notice to the holders of its Common Stock. Upon the closing of the Rights Offering, the Company issued an aggregate of 2,533,853 shares of Common Stock and received aggregate net proceeds of $255,412, after giving effect to the Representative Affiliate Transactions (as defined below), which it intended to use primarily for general corporate purposes and expenses associated with the IPO.